The US Protein Hydrolysates Market was valued at USD 2,150 Million in 2025 and is projected to reach USD 4,950 Million by 2035, at a CAGR of 7.8% from 2024 to 2035. The market is driven by rising demand across sports nutrition, infant formula, and clinical nutrition sectors, backed by continuous innovation in protein processing techniques.
The economic impact of tariffs on "US Protein Hydrolysates Market".
Market Growth Drivers
Rising Demand for Nutritional Supplements: The increasing focus on health and wellness, especially post-pandemic, has significantly boosted the demand for protein hydrolysates in sports nutrition and dietary supplements. Companies like Arla Foods Ingredients have introduced advanced whey protein hydrolysate products targeting fitness enthusiasts and athletes seeking rapid muscle recovery and improved performance.
Expansion in Infant Nutrition: With the heightened awareness of infant nutrition and hypoallergenic formulas, the US market has seen a surge in demand for protein hydrolysates as a key ingredient. Nestlé Health Science recently expanded its range of infant and pediatric formulas incorporating extensively hydrolyzed proteins to address cow’s milk protein allergy and improve infant gut health.
Market Trends
Clean Label and Allergen-Free Trends: Consumers are pushing brands to develop clean label and allergen-free protein hydrolysate products, with transparency in ingredient sourcing. Companies like Kerry Group are focusing on plant-based protein hydrolysates with simple, traceable ingredients, targeting consumers with dietary restrictions.
Functional Food and RTD Beverages: The inclusion of protein hydrolysates in ready-to-drink (RTD) beverages and functional foods is gaining traction. ADM (Archer Daniels Midland) has expanded its product portfolio with hydrolysate-enhanced beverages that promise faster absorption and greater health benefits, appealing to both fitness and mainstream consumers.
Market Opportunity
Growth in Geriatric Nutrition: As the aging population in the US grows, there is increasing opportunity for protein hydrolysates in clinical and geriatric nutrition. Companies such as Abbott Laboratories are exploring formulations designed for elderly patients to support muscle maintenance and recovery.
Plant-Based Protein Innovations: With market traction shifting towards sustainability, companies like Cargill are developing plant-based protein hydrolysates as meat and dairy alternatives, opening expansion opportunities in vegan and vegetarian segments.
US Protein Hydrolysates Market Revenue (USD Million), 2020-2035
The revenue trend for the US Protein Hydrolysates Market displays a steady upward trajectory from 2020 to 2035. Beginning at USD 1,250 Million in 2020, the market experienced accelerated growth post-2022, reaching USD 2,150 Million in 2025. This expansion is fueled by increasing applications and innovation in nutrition sectors. Post-2025, sustained investment in clinical, sports, and infant nutrition continues driving market value to USD 4,950 Million by 2035. The chart highlights consistent CAGR growth, reflecting strong consumer and industry adoption. The later years suggest opportunities for new entrants as demand outpaces supply.
US Protein Hydrolysates Market Share by Regions (%), 2025
In 2025, the Northeast holds the largest share of the US Protein Hydrolysates Market at 32%, primarily due to high population density and robust healthcare infrastructure. The Midwest follows with 24%, while the South accounts for 21% driven by expanding manufacturing bases and nutraceutical adoption. The West holds 17%, underpinned by rapid innovation in health foods and beverages. The remaining 6% comes from Other regions including non-contiguous states. The regional split illustrates where leading market growth and consumption are likely to occur in the coming decade.
Recent Developments
In March 2024, Arla Foods Ingredients launched Lacprodan® HYDRO.Rebuild, a new whey protein hydrolysate aimed at enhancing muscle recovery post-exercise. The product uses advanced hydrolysis technology to improve absorption rates, positioning Arla Foods at the forefront of sports nutrition innovation.
In April 2024, Nestlé Health Science introduced its Althéra® and Alfamino® formulas to the US market, expanding its portfolio of hypoallergenic infant formulas based on protein hydrolysates. These products cater to infants with severe cow's milk protein allergy, reflecting Nestlé's commitment to specialized nutrition solutions.
In May 2024, ADM announced a partnership with a major beverage manufacturer to co-develop a new line of RTD beverages fortified with their latest plant-based protein hydrolysates. This move accelerates ADM's expansion into functional beverages and showcases ongoing investment in protein innovation.
Press Releases